These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35571866)

  • 21. In Silico Screening of Novel TMPRSS2 Inhibitors for Treatment of COVID-19.
    Wang S; Fang X; Wang Y
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developing a SARS-CoV-2 main protease binding prediction random forest model for drug repurposing for COVID-19 treatment.
    Liu J; Xu L; Guo W; Li Z; Khan MKH; Ge W; Patterson TA; Hong H
    Exp Biol Med (Maywood); 2023 Nov; 248(21):1927-1936. PubMed ID: 37997891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting mechanism for SARS-CoV-2
    Zhao X; Luo S; Huang K; Xiong D; Zhang JZH; Duan L
    Nanoscale; 2021 Nov; 13(45):19218-19237. PubMed ID: 34787160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2).
    Rahman N; Basharat Z; Yousuf M; Castaldo G; Rastrelli L; Khan H
    Molecules; 2020 May; 25(10):. PubMed ID: 32408547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In silico investigation of the therapeutic and prophylactic potential of medicinal substances bearing guanidine moieties against COVID-19.
    Esam Z; Akhavan M; Lotfi M; Pourmand S; Bekhradnia A
    Chem Zvesti; 2023; 77(2):1129-1148. PubMed ID: 36312321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational screening combined with well-tempered metadynamics simulations identifies potential TMPRSS2 inhibitors.
    Sharanya CS; Wilbee DS; Sathi SN; Natarajan K
    Sci Rep; 2024 Jul; 14(1):16197. PubMed ID: 39003338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of SARS-CoV-2 cell entry: insight from
    Gyebi GA; Adegunloye AP; Ibrahim IM; Ogunyemi OM; Afolabi SO; Ogunro OB
    J Biomol Struct Dyn; 2022 Mar; 40(5):2121-2145. PubMed ID: 33089728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease.
    Kreutzberger AJB; Sanyal A; Ojha R; Pyle JD; Vapalahti O; Balistreri G; Kirchhausen T
    J Virol; 2021 Oct; 95(21):e0097521. PubMed ID: 34406858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tafenoquine and its derivatives as inhibitors for the severe acute respiratory syndrome coronavirus 2.
    Chen Y; Yang WH; Chen HF; Huang LM; Gao JY; Lin CW; Wang YC; Yang CS; Liu YL; Hou MH; Tsai CL; Chou YZ; Huang BY; Hung CF; Hung YL; Wang WJ; Su WC; Kumar V; Wu YC; Chao SW; Chang CS; Chen JS; Chiang YP; Cho DY; Jeng LB; Tsai CH; Hung MC
    J Biol Chem; 2022 Mar; 298(3):101658. PubMed ID: 35101449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 Entry Inhibitors Targeting Virus-ACE2 or Virus-TMPRSS2 Interactions.
    Lin H; Cherukupalli S; Feng D; Gao S; Kang D; Zhan P; Liu X
    Curr Med Chem; 2022; 29(4):682-699. PubMed ID: 33881969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Would the Development of a Multitarget Inhibitor of 3CL
    Dos Santos Nascimento IJ; de Moura RO
    Med Chem; 2023; 19(5):405-412. PubMed ID: 36221875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strong Binding of Leupeptin with TMPRSS2 Protease May Be an Alternative to Camostat and Nafamostat for SARS-CoV-2 Repurposed Drug: Evaluation from Molecular Docking and Molecular Dynamics Simulations.
    Ramakrishnan J; Kandasamy S; Iruthayaraj A; Magudeeswaran S; Chinnasamy K; Poomani K
    Appl Biochem Biotechnol; 2021 Jun; 193(6):1909-1923. PubMed ID: 33512650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural analysis of experimental drugs binding to the SARS-CoV-2 target TMPRSS2.
    Huggins DJ
    J Mol Graph Model; 2020 Nov; 100():107710. PubMed ID: 32829149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential protease inhibitors and their combinations to block SARS-CoV-2.
    Abhinand CS; Nair AS; Krishnamurthy A; Oommen OV; Sudhakaran PR
    J Biomol Struct Dyn; 2022 Feb; 40(2):903-917. PubMed ID: 32924827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection.
    Iwata-Yoshikawa N; Okamura T; Shimizu Y; Hasegawa H; Takeda M; Nagata N
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consensus docking and MM-PBSA computations identify putative furin protease inhibitors for developing potential therapeutics against COVID-19.
    Dankwa B; Broni E; Enninful KS; Kwofie SK; Wilson MD
    Struct Chem; 2022; 33(6):2221-2241. PubMed ID: 36118173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models.
    Mykytyn AZ; Breugem TI; Geurts MH; Beumer J; Schipper D; van Acker R; van den Doel PB; van Royen ME; Zhang J; Clevers H; Haagmans BL; Lamers MM
    J Virol; 2023 Aug; 97(8):e0085123. PubMed ID: 37555660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
    Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785634
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Prajapati KS; Singh AK; Kushwaha PP; Shuaib M; Maurya SK; Gupta S; Senapati S; Singh SP; Waseem M; Kumar S
    Vegetos; 2023; 36(2):701-720. PubMed ID: 35729946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
    Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S
    J Genet; 2021; 100(1):. PubMed ID: 33707363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.